Compare VIV & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VIV | DGX |
|---|---|---|
| Founded | 1973 | 1967 |
| Country | Brazil | United States |
| Employees | 35010 | N/A |
| Industry | Telecommunications Equipment | Medical Specialities |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.8B | 23.1B |
| IPO Year | 1998 | 1996 |
| Metric | VIV | DGX |
|---|---|---|
| Price | $14.08 | $190.17 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 13 |
| Target Price | $14.80 | ★ $214.38 |
| AVG Volume (30 Days) | ★ 1.0M | 905.8K |
| Earning Date | 05-12-2026 | 04-21-2026 |
| Dividend Yield | ★ 2.47% | 1.82% |
| EPS Growth | N/A | ★ 13.78 |
| EPS | N/A | ★ 2.24 |
| Revenue | N/A | ★ $11,035,000,000.00 |
| Revenue This Year | $9.22 | $7.53 |
| Revenue Next Year | $5.52 | $3.77 |
| P/E Ratio | ★ $22.12 | $83.41 |
| Revenue Growth | N/A | ★ 11.78 |
| 52 Week Low | $9.73 | $164.65 |
| 52 Week High | $17.26 | $213.50 |
| Indicator | VIV | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 32.99 | 45.89 |
| Support Level | $11.81 | $186.91 |
| Resistance Level | $16.46 | $191.91 |
| Average True Range (ATR) | 0.34 | 4.16 |
| MACD | -0.19 | -0.21 |
| Stochastic Oscillator | 7.71 | 40.36 |
Telefonica Brasil, known as Vivo, is the largest wireless carrier in Brazil with 103 million customers, which is equal to about 38% market share. The firm is strongest in the postpaid business, where it has 72 million customers, or about 40% share of this market. Wireless services and equipment contribute about 70% of total revenue. Vivo is the incumbent fixed-line telephone operator in Sao Paulo state and also owns an extensive fiber network across the country. The firm provides internet access to 8 million households on this network. The firm also sells pay-TV and phone services to its fixed-line customers. Finally, corporate data and IT services, including cloud computing support, contribute about 10% of total revenue.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.